Polyamines in pancreatic cancer: reshaping the immunosuppressive tumor microenvironment
Cancer Letters · 2025-11 · 633 · 218016
DOI: 10.1016/j.canlet.2025.218016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2025-11. Verfasst von Shijuan Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Department, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medic…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Pancreatic Neoplasms, Polyamines, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 170 Literaturangaben. Gefördert von: Peking Union Medical College Hospital, National Natural Science Foundation of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy, characterized by its aggressiveness and poor outcomes. Emerging evidence implicates dysregulated polyamine metabolism as a key driver of PDAC immunosuppression, yet the mechanisms underlying this metabolic-immune crosstalk remain poorly defined. This review summarizes recent findings demonstrating that PDAC is uniquely dependent on glutamine-derived ornithine for de novo polyamine synthesis, orchestrated by the KRAS-MYC axis. Through metabolic reprogramming of immune cells, polyamines polarize tumor-associated macrophages toward M2-like phenotypes, expand myeloid-derived suppressor cells, and impair T cell activation. Crucially, the immunomodulatory effects of polyamines are source-dependent: tumor-derived spermidine promotes T cell exhaustion, whereas dietary spermidine enhances antitumor immunity through fatty acid oxidation. Preclinical studies have highlighted that polyamine-targeted therapy, including biosynthesis inhibitors, arginine deprivation agents and polyamine analogue, is a promising strategy to reverse immunosuppression and enhance the efficacy of checkpoint inhibitors. These evidences establish polyamine metabolism as a therapeutic vulnerability in PDAC, offering novel diagnostic tools and combination regimens to overcome therapeutic resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- General Surgery Department, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.…
Förderung
- Peking Union Medical College Hospital
- National Natural Science Foundation of China
- Chinese Academy of Sciences
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Jiang, S., Ren, B., Ding, C., Du, C., Cao, Z., Yang, G., Huang, H., & Zhang, T. (2025). Polyamines in pancreatic cancer: reshaping the immunosuppressive tumor microenvironment. Cancer Letters, 633, 218016. https://doi.org/10.1016/j.canlet.2025.218016
Vancouver
Jiang S, Ren B, Ding C, Du C, Cao Z, Yang G, et al. Polyamines in pancreatic cancer: reshaping the immunosuppressive tumor microenvironment. Cancer Letters. 2025;633:218016. doi:10.1016/j.canlet.2025.218016
BibTeX
@article{Jiang2025,
author = {Jiang, Shijuan and Ren, Bo and Ding, Chen and Du, Changwei and Cao, Zhe and Yang, Gang and Huang, Hua and Zhang, Taiping},
title = {Polyamines in pancreatic cancer: reshaping the immunosuppressive tumor microenvironment},
journal = {Cancer Letters},
year = {2025},
volume = {633},
pages = {218016},
doi = {10.1016/j.canlet.2025.218016}
}
EUVIMED